Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$1.08 - $2.54 $24,685 - $58,056
-22,857 Reduced 1.65%
1,365,300 $1.62 Million
Q2 2023

Aug 11, 2023

BUY
$2.31 - $3.06 $52,513 - $69,562
22,733 Added 1.66%
1,388,157 $3.4 Million
Q1 2023

May 12, 2023

BUY
$3.13 - $7.31 $316 - $738
101 Added 0.01%
1,365,424 $4.27 Million
Q2 2022

Aug 11, 2022

SELL
$4.58 - $17.13 $5.13 Million - $19.2 Million
-1,120,747 Reduced 45.08%
1,365,323 $11.3 Million
Q1 2022

May 13, 2022

SELL
$12.3 - $18.33 $1,426 - $2,126
-116 Reduced -0.0%
2,486,070 $41.3 Million
Q4 2021

Feb 11, 2022

BUY
$7.44 - $16.72 $1.55 Million - $3.48 Million
207,837 Added 9.12%
2,486,186 $41.6 Million
Q2 2021

Aug 13, 2021

BUY
$4.93 - $6.46 $1.24 Million - $1.62 Million
251,400 Added 12.4%
2,278,349 $12.4 Million
Q4 2020

Feb 10, 2021

BUY
$4.77 - $6.58 $233 - $322
49 Added 0.0%
2,026,949 $10.6 Million
Q1 2020

May 13, 2020

BUY
$2.77 - $5.75 $4.71 Million - $9.78 Million
1,700,000 Added 520.04%
2,026,900 $8.84 Million
Q2 2019

Aug 14, 2019

SELL
$7.09 - $21.9 $53,884 - $166,440
-7,600 Reduced 2.27%
326,900 $2.52 Million
Q3 2018

Nov 13, 2018

SELL
$15.5 - $21.41 $240,250 - $331,855
-15,500 Reduced 4.43%
334,500 $7.16 Million
Q2 2018

Aug 14, 2018

BUY
$17.15 - $17.79 $6 Million - $6.23 Million
350,000 New
350,000 $6.06 Million

Others Institutions Holding KZR

About Kezar Life Sciences, Inc.


  • Ticker KZR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,369,504
  • Market Cap $510M
  • Description
  • Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...
More about KZR
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.